Zobrazeno 1 - 10
of 326
pro vyhledávání: '"Irene Lorand‐Metze"'
Autor:
Arthur Gomes Oliveira Braga, Katia Borgia Barbosa Pagnano, Marina Dal'Bó Pelegrini Campioni, Ana Beatriz Pascoal Lopes, Gislaine Oliveira Duarte, Konradin Metze, Irene Lorand-Metze
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss 3, Pp 268-272 (2024)
Introduction: Treatment-free remission (TFR) is successful in half of the patients with chronic myeloid leukemia who discontinue Imatinib (IM) after sustained molecular response. Methods: In a prospective trial, we used pioglitazone for 3 months befo
Externí odkaz:
https://doaj.org/article/844ca4a2161b431180b6697474d2849e
Autor:
Patrícia Gama, Tayana Mello, Rafaela M.S. Araújo, Maria Rafaela M.B. Silva, Ana Paula F. Dametto, Fernanda G.P. Cunha, Irene Lorand-Metze
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp 10- (2023)
A LLA L3 (ou de células de Burkitt) tem sido definida com forma leucêmica do linfoma de Burkitt na classificação atual da OMS. É uma neoplasia associada à presença do EBV, e recentemente alguns trabalhos têm mostrado que o vírus pode modular
Externí odkaz:
https://doaj.org/article/ec6741ce445841c6bcba2f387f657df4
Autor:
Míriam P. Beltrame, Elizabeth Xisto Souto, Mihoko Yamamoto, Felipe M Furtado, Elaine Sobral da Costa, Alex Freire Sandes, Glicínia Pimenta, Geraldo Barroso Cavalcanti Júnior, Maria Cláudia Santos-Silva, Irene Lorand-Metze, Maura R V Ikoma-Colturato
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss 4, Pp 499-506 (2021)
Introduction: Flow cytometry has become an increasingly important tool in the clinical laboratory for the diagnosis and monitoring of many hematopoietic neoplasms. This method is ideal for immunophenotypic identification of cellular subpopulations in
Externí odkaz:
https://doaj.org/article/3e81e384c5e1424884a4fa855d4648a4
Autor:
Muriel Silva Moura, Thais Celi Lopes Benevides, Marcia Torresan Delamain, Gislaine Oliveira Duarte, Priscila Oliveira Percout, Maria Almeida Dias, Roberto Zulli, Carmino Antonio de Souza, Irene Lorand-Metze, Katia Borgia Barbosa Pagnano
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 41, Iss 4, Pp 329-334 (2019)
Introduction: The incidence of grade 3–4 anemia was reported to be 3% with imatinib therapy for newly diagnosed chronic myeloid leukemia (CML) in the chronic phase (CP). However, there are few data regarding the causes and the development of anemia
Externí odkaz:
https://doaj.org/article/214c7951e2014ffda148b92eb53b2649
Management of chronic myeloid leukemia during pregnancy: a retrospective analysis at a single center
Autor:
Ariella Cássia de Moura, Márcia Torresan Delamain, Gislaine Borba Oliveira Duarte, Irene Lorand-Metze, Cármino Antônio de Souza, Kátia Borgia Barbosa Pagnano
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 41, Iss 2, Pp 125-128 (2019)
We analyzed the management and outcomes of pregnancies of patients with chronic myeloid leukemia at a single center over fifteen years. Among the 203 CML female patients, there were ten pregnancies in seven women, all of them not planned. In three ca
Externí odkaz:
https://doaj.org/article/6237cf93911240288dd2d385ebb09371
Autor:
Maria Emilia Seren Takahashi, Irene Lorand-Metze, Carmino Antonio de Souza, Claudio Tinoco Mesquita, Fernando Amorim Fernandes, José Barreto Campello Carvalheira, Celso Dario Ramos
Publikováno v:
Metabolites, Vol 11, Iss 12, p 875 (2021)
Multiple myeloma (MM) accounts for 10–15% of all hematologic malignancies, as well as 20% of deaths related to hematologic malignant tumors, predominantly affecting bone and bone marrow. Positron emission tomography/computed tomography with 18F-flu
Externí odkaz:
https://doaj.org/article/1a4d0f0b2a944027b42d0f241c3d57de
Autor:
Vitória Ceni-Silva, Kátia Pagnano, Gislaine Duarte, Marina Pellegrini, Bruno Duarte, Konradin Metze, Irene Lorand-Metze
Publikováno v:
Diagnostics, Vol 11, Iss 11, p 1988 (2021)
(1) Background: Acute promyelocytic leukemia is curable, but bleeding complications still provoke a high early mortality. Therefore, a fast diagnosis is needed for timely starting treatment. We developed a diagnostic algorithm using flow cytometric f
Externí odkaz:
https://doaj.org/article/8a6f91922c1c49ea99cffd384f7a44ce
Autor:
Beatriz Felicio Ribeiro, Eliana C.M. Miranda, Dulcinéia Martins de Albuquerque, Márcia T. Delamain, Gislaine Oliveira-Duarte, Maria Helena Almeida, Bruna Vergílio, Rosana Antunes da Silveira, Vagner Oliveira-Duarte, Irene Lorand-Metze, Carmino A. De Souza, Katia B.B. Pagnano
Publikováno v:
Clinics, Vol 70, Iss 8, Pp 550-555 (2015)
OBJECTIVE:To evaluate hematological, cytogenetic and molecular responses as well as the overall, progression-free and event-free survivals of chronic myeloid leukemia patients treated with a third tyrosine kinase inhibitor after failing to respond to
Externí odkaz:
https://doaj.org/article/a4a165ab80c94083b9607aae3a73c740
Autor:
João Agostinho Machado-Neto, Paula de Melo Campos, Dulcinéia Martins de Albuquerque, Fernando Ferreira Costa, Irene Lorand-Metze, Sara Terezinha Olalla Saad, Fabiola Traina
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 37, Iss 3, Pp 211-214 (2015)
Externí odkaz:
https://doaj.org/article/b8d0ab85400245d99d7ae56a4b493c64
Publikováno v:
Clinics, Vol 70, Iss 5, Pp 322-325 (2015)
OBJECTIVES: In Brazil, imatinib mesylate is supplied as the first-line therapy for chronic myeloid leukemia in the chronic phase through the public universal healthcare program, Sistema Único de Saúde (SUS). We studied the socio-demographic factors
Externí odkaz:
https://doaj.org/article/6992fc06362f4452867f709100e3e862